Monte Rosa Therapeutics Overview

Life ScienceCompany

Was Monte Rosa Therapeutics formerly PE-backed?

Yes. Monte Rosa Therapeutics was formerly owned by 2 private investors.

Where is Monte Rosa Therapeutics headquartered?

Monte Rosa Therapeutics is headquartered in Boston, Massachusetts.

How many employees does Monte Rosa Therapeutics have?

Monte Rosa Therapeutics has 133 employees.

What sector is Monte Rosa Therapeutics in?

Monte Rosa Therapeutics is a life science company.

When was Monte Rosa Therapeutics founded?

Monte Rosa Therapeutics was founded in 2018.

Monte Rosa Therapeutics

Monte Rosa Therapeutics, Inc.

321 Harrison Avenue, Suite 900,
Boston, Massachusetts 02118
United States,
(617) 949-2643
www.monterosatx.com

Monte Rosa Therapeutics is a biotechnology company developing molecular glues to degrade disease-causing proteins. The company has developed a platform to rationally design small molecules that reprogram ubiquitin ligases to eliminate disease drivers previously deemed undruggable. The company’s drug discovery platform combines diverse and proprietary chemical libraries of small molecule protein degraders with in-house proteomics, structural biology, machine learning-based target selection, and computational chemistry capabilities to predict and obtain protein degradation profiles. Monte Rosa Therapeutics was founded in 2018 and is based in Boston, Massachusetts.



Try Mergr Free — See This and 221,377+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 215K M&A Transactions
  • 217K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.